NRX Pharmaceuticals's three largest insider shareholders as of March 23, 2026 are Daniel C. Javitt (TenPercentOwner, 9.63Mn shares), Lending Group Llc Brac (TenPercentOwner, 590.43K shares), Chaim Hurvitz (Director, 570.00K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Jonathan C Javitt | - | 0 | 12,899,997 | 09 Dec, 2022 |
| Daniel C. Javitt | - | 0 | 9,872,901 | 02 Aug, 2022 |
| Daniel C. Javitt | - | 0 | 9,634,793 | 01 Dec, 2022 |
| Chaim Hurvitz | - | 570,000 | 0 | 11 Sep, 2023 |
| Chaim Hurvitz | - | 500,000 | 0 | 23 Nov, 2022 |
| Aaron Gorovitz | - | 0 | 105,000 | 11 Sep, 2023 |
| Jonathan C Javitt | Chairman And Chief Scientist | 84,634 | 0 | 17 Dec, 2024 |
| Stephen H Willard | Chief Executive Officer | 50,000 | 0 | 18 Dec, 2022 |
| Voorhees Seth Van | Chief Financial Officer | 46,337 | 0 | 18 Dec, 2022 |
| Patrick John Flynn | - | 1,750 | 40,209 | 28 Nov, 2022 |
| Alessandra Daigneault | General Counsel Secretary | 31,584 | 0 | 02 Nov, 2021 |
| Herbert Raymond Mcmaster | - | 18,300 | 0 | 02 Nov, 2021 |
| Voorhees Seth Van | Chief Financial Officer | 0 | 16,377 | 28 Nov, 2022 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 27 Jan, 2026 | Joseph Michael Casper | Stock Option (right to buy) | A | 100,000 | $0.00 | 100,000 | D | A |
| 07 Feb, 2025 | Michael S Abrams | Stock Option (right to buy) | A | 50,000 | $0.00 | 50,000 | D | A |
| 17 Dec, 2024 | Jonathan C Javitt | Common Stock | A | 40,000 | $1.17 | 84,634 | D | P |
| 30 Aug, 2023 | Aaron Gorovitz | Common Stock, par value $0.001 per share | A | 35,000 | $0.32 | 105,000 | I | P |
| 30 Aug, 2023 | Chaim Hurvitz | Common Stock, par value $0.001 per share | A | 70,000 | $0.29 | 570,000 | D | P |
| 23 Aug, 2023 | Jonathan C Javitt | Common Stock | A | 100,000 | $0.33 | 446,332 | D | P |
| 22 Aug, 2023 | Jonathan C Javitt | Common Stock | A | 200,000 | $0.32 | 346,332 | D | P |
| 16 Dec, 2022 | Stephen H Willard | Common Stock, par value $0.001 per share | A | 50,000 | $1.17 | 50,000 | D | P |
| 25 Nov, 2022 | Voorhees Seth Van | Common Stock, par value $0.001 per share | A | 8,716 | $1.12 | 8,716 | D | P |
| 16 Dec, 2022 | Voorhees Seth Van | Common Stock, par value $0.001 per share | A | 30,000 | $1.10 | 46,337 | D | P |
| 25 Nov, 2022 | Voorhees Seth Van | Common Stock, par value $0.001 per share | A | 600 | $1.10 | 9,316 | D | P |
| 25 Nov, 2022 | Voorhees Seth Van | Common Stock, par value $0.001 per share | A | 7,021 | $1.11 | 16,337 | D | P |
| 07 Dec, 2022 | Jonathan C Javitt | Common Stock, par value $0.001 per share | D | 400,000 | $1.00 | 12,899,997 | I | S |
| 29 Nov, 2022 | Daniel C. Javitt | common stock | D | 13,730 | $1.50 | 9,643,234 | I | S |
| 30 Nov, 2022 | Daniel C. Javitt | common stock | D | 8,441 | $1.50 | 9,634,793 | I | S |
| 25 Nov, 2022 | Voorhees Seth Van | Common Stock, par value $0.001 per share | A | 8,716 | $1.12 | 8,716 | I | P |
| 28 Nov, 2022 | Patrick John Flynn | Common Stock, par value $0.001 per share | A | 2,500 | $1.25 | 37,709 | I | P |
| 25 Nov, 2022 | Voorhees Seth Van | Common Stock, par value $0.001 per share | A | 600 | $1.10 | 9,316 | I | P |
| 28 Nov, 2022 | Patrick John Flynn | Common Stock, par value $0.001 per share | A | 2,500 | $1.25 | 40,209 | I | P |
| 25 Nov, 2022 | Voorhees Seth Van | Common Stock, par value $0.001 per share | A | 7,021 | $1.11 | 16,377 | I | P |